COMPOUND SERVING AS DDR1 KINASE INHIBITOR, AND MEDICINE

Abstract

The present invention provides a compound represented by general formula[1] and having a DDR1 kinase inhibitory activity, a pharmaceutically acceptable salt of the compound, or a solvate of the compound or the pharmaceutically acceptable salt (in the formula, R1 represents a hydrogen atom, a halogen atom, an optionally substituted alkyl group; Het represents a 5- to 10-membered heteroaryl group; L1 represents -CO-NH- or -CRa=CRb-; X represents C-Rc; R2 represents a C1-C6 haloalkoxy group or a C1-C6 haloalkyl group; R3, R4 and a carbon atom to which these residues are bound together form an optionally substituted C3-C6 cycloalkyl group or an optionally substituted heterocycloalkyl group).

Documents